Previous close | 29.85 |
Open | 29.90 |
Bid | 29.85 |
Ask | 30.35 |
Strike | 60.00 |
Expiry date | 2024-03-15 |
Day's range | 29.85 - 29.90 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Pfizer and Amazon Web Services are just another example of how artificial intelligence is working in the background in healthcare.
As demand for novel IBD treatments rises, investment in this dynamic sector could be rewarding. Some of the key players in the market are AbbVie (ABBV), J&J (JNJ), Lilly (LLY) and Pfizer (PFE).
Positive data from Merck's (MRK) phase III study on V116, an investigational, 21-valent pneumococcal conjugate vaccine, supports the immunogenicity of V116 compared to standard of care.